An early discharge strategy with rivaroxaban reduces hospital lengths of stay and healthcare costs for patients with low-risk pulmonary embolism (LRPE)—without compromising their safety—suggests a study published in Academic Emergency Medicine.

The 200 and 250 millimeter lengths of Medtronic’s IN.PACT Admiral drug-coated balloon gained FDA approval to treat long superficial artery (SFA) lesions in patients with peripheral artery disease (PAD), the company announced June 15.

New research suggests flavorings in electronic cigarettes, or e-cigarettes—including mint, vanilla, cinnamon and strawberry—can adversely affect endothelial cells, according to a study published June 14 in Arteriosclerosis, Thrombosis, and Vascular Biology.

A new report from the Centers for Disease Control and Prevention (CDC) suggests 5.5 percent more rural Americans are obese than their metropolitan counterparts.

A new study published in JAMA: Cardiology on June 13 suggests black patients have a higher risk of atherosclerotic cardiovascular disease (ASCVD) and are less likely to receive guideline-appropriate statin therapy.

Systolic blood pressures above 130 millimeters of mercury in middle age were associated with an increased risk of dementia later on, according to a longitudinal study published June 12 in the European Heart Journal.

Mutations in the CHD4 gene are known contributors to congenital heart defects. Biologists at the University of North Carolina School of Medicine believe they are beginning to understand why.

Coronary artery bypass graft (CABG) surgeries, in particular, were strongly linked to the life-threatening condition—carrying a 14-fold increase in relative risk, among the top five of all inpatient procedures analyzed.